.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
US Army
Citi
Julphar
McKesson
UBS
Johnson and Johnson
Medtronic
Cerilliant
Chinese Patent Office

Generated: November 23, 2017

DrugPatentWatch Database Preview

Drugs with Dosage: POWDER

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Abbvie
NORISODRINE
isoproterenol sulfate
POWDER;INHALATION006905-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► SubscribePOWDER;INHALATION
Abbvie
NORISODRINE
isoproterenol sulfate
POWDER;INHALATION006905-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► SubscribePOWDER;INHALATION
Apothekernes
BACITRACIN
bacitracin
POWDER;FOR RX COMPOUNDING061699-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► SubscribePOWDER;FOR RX COMPOUNDING
Bristol Myers
QUESTRAN
cholestyramine
POWDER;ORAL016640-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► SubscribePOWDER;ORAL
Bristol Myers
QUESTRAN
cholestyramine
POWDER;ORAL016640-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► SubscribePOWDER;ORAL
Bristol Myers Squibb
REZIPAS
aminosalicylic acid resin complex
POWDER;ORAL009052-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► SubscribePOWDER;ORAL
Century Pharms
P.A.S. SODIUM
aminosalicylate sodium
POWDER;ORAL080947-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► SubscribePOWDER;ORAL
Concordia Pharms Inc
KAYEXALATE
sodium polystyrene sulfonate
POWDER;ORAL, RECTAL011287-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► SubscribePOWDER;ORAL, RECTAL
Delcor Asset Corp
MYCOSTATIN
nystatin
POWDER;TOPICAL060578-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► SubscribePOWDER;TOPICAL
Hexcel
POTASSIUM AMINOSALICYLATE
potassium aminosalicylate
POWDER;ORAL080098-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► SubscribePOWDER;ORAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Fuji
Healthtrust
Chinese Patent Office
Citi
Mallinckrodt
Argus Health
Harvard Business School
Daiichi Sankyo
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot